Soft Tissue Repair Market - Global Forecast to 2030
商品番号 : SMB-13631
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年7月 |
| ページ数 | 276 |
| 図表数 | 336 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
本レポートは、軟部組織修復市場を分析し、製品、用途、エンドユーザー、地域といった様々なセグメントに基づいて、市場規模と将来の成長ポテンシャルを推定することを目的としています。また、主要プレーヤーの競合分析に加え、企業概要、サービス内容、最近の動向、主要な市場戦略も掲載しています。
The soft tissue repair market is projected to reach USD 20.5 million by 2030 from USD 15.9 million in 2025, growing at a CAGR of 5.1 % from 2025 to 2030.
軟部組織修復市場は、2025年の1,590万米ドルから2030年には2,050万米ドルに達し、2025年から2030年にかけて5.1％のCAGRで成長すると予測されています。
The rising demand for soft tissue repair is growing rapidly due to the increasing volume of surgeries and the growing prevalence of severe trauma injuries.
手術件数の増加と重度外傷の発生率の増加により、軟部組織修復の需要が急速に高まっています。
The primary objective of soft tissue repair instruments and consumables is to fortify compromised tissue or surgically address torn or damaged soft tissue structures. The steady market growth in this sector can be attributed to several key factors, including the proliferation of innovative products across various subfields of soft tissue repair, the increasing incidence of sports-related injuries among the youth demographic, and the aging population, which is more prone to orthopedic soft tissue injuries and hernias. Moreover, advancements in healthcare infrastructure, coupled with heightened government investment in health systems and rising disposable incomes, particularly in Latin America and the Asia Pacific regions, are significantly propelling market expansion. However, challenges remain that could hinder progress, such as limited insurance reimbursements, intricate regulatory landscapes, and the high costs associated with surgical interventions.
軟部組織修復器具および消耗品の主な目的は、損傷した組織を強化し、断裂または損傷した軟部組織構造を外科的に治療することです。この分野の着実な市場成長は、軟部組織修復の様々な分野における革新的な製品の普及、若年層におけるスポーツ関連の傷害発生率の増加、そして整形外科的な軟部組織傷害やヘルニアに罹患しやすい高齢化など、いくつかの重要な要因に起因しています。さらに、医療インフラの進歩、医療制度への政府投資の増大、そして特にラテンアメリカとアジア太平洋地域における可処分所得の増加が、市場拡大を大きく推進しています。しかしながら、保険償還の制限、複雑な規制環境、外科的介入に伴う高額な費用など、進歩を阻む可能性のある課題も依然として残っています。
“By product, the tissue patches/meshes segment accounted for the largest market share in the soft tissue repair market in 2024.”
The tissue patches/meshes segment commanded the largest share in the soft tissue repair market in 2024, primarily due to its extensive applications in hernia repair, pelvic organ prolapse, and various reconstructive procedures that necessitate the reinforcement or replacement of compromised soft tissues. The ascendancy of these products can be attributed to their structural support capabilities, reduced operative time, and improved patient outcomes. The rising adoption of both biologic and synthetic meshes, which exhibit enhanced integration with native tissues and a lower incidence of complications, has further fueled demand. Recent advancements in mesh technology, focusing on the development of lightweight, biocompatible, and absorbable polymers, have significantly bolstered their clinical acceptance and expanded their applications. Furthermore, the increasing prevalence of obesity, coupled with an aging demographic and a growing volume of surgeries requiring tissue reinforcement and reconstruction, contributes to the segment’s robust growth. Moreover, the favorable reimbursement landscape for hernia and soft tissue repair procedures in developed markets enhances the adoption of patches and meshes, thereby solidifying their leading role within the product portfolio.
“By application, the skin repair segment held the third-largest market share in the soft tissue repair market in 2024.”
In the context of application types within the soft tissue repair market, skin repair represents the third-largest segment. A key factor influencing this segment is the high prevalence of chronic wounds, which necessitate effective skin repair interventions, such as those for diabetic foot ulcers, pressure ulcers, and venous leg ulcers. The growing incidence of burn injuries and traumatic skin wounds further escalates the demand for advanced wound care and skin grafting solutions. Recent advancements in wound care technologies, including innovations in collagen dressings, growth factor therapies, and bioengineered skin substitutes, have markedly improved treatment efficacy. Moreover, heightened awareness among both patients and healthcare practitioners regarding the critical importance of timely wound management has played a substantial role in this market’s expansion. Coupled with the increasing availability of insurance coverage for chronic wound care in many developed nations, these factors collectively contribute to the sustained growth of the skin repair segment within the broader soft tissue repair market.
“By end user, the hospitals & clinics segment had the largest market share in the soft tissue repair market in 2024.”
Hospitals and clinics dominate the market share largely due to their substantial patient throughput, which drives the demand for a wide spectrum of treatments ranging from routine procedures to complex surgical interventions. These institutions are often the primary access points for acute conditions such as trauma, sports-related injuries, and other ailments that require advanced soft tissue repair techniques. Equipped with highly qualified medical personnel and sophisticated infrastructure, hospitals often feature specialized departments—such as sports medicine, general surgery, and orthopedics—that enable comprehensive diagnostic capabilities and surgical interventions. Additionally, larger hospitals and comprehensive care clinics leverage economies of scale, allowing them to procure state-of-the-art surgical products and cutting-edge technologies. Their substantial funding and established relationships with leading medical device manufacturers enhance their ability to adopt and implement innovative solutions in patient care.
“By region, Europe had the second-largest market share in the soft tissue repair market in 2024.”
Europe is in the second leading position in the soft tissue repair market due to a combination of elements. A strong healthcare infrastructure backs the region, which facilitates widespread access to advanced surgical procedures and technologies. There is an unnatural need for soft tissue repair offerings brought about by the convergence of extensive age-related hernias and orthopedic diseases with a growing elderly population. European countries have strong reimbursement systems in place, along with favorable regulatory environments, which collectively encourage the uptake of innovative medical devices. The region is topped up by sustained funding for healthcare research, along with widespread adoption of early surgical techniques and the formation of leading medical device firms. The demand for soft tissue repair products in Europe has gained momentum with the increased awareness of patients and healthcare specialists regarding minimally invasive treatments and improved post-surgical results.
A breakdown of the primary participants (supply-side) for the soft tissue repair market referred to for this report is provided below:
- By Company Type: Tier 1–35%, Tier 2–40%, and Tier 3–25%
- By Designation: C-level–20%, Director Level 35%, and Others–45%
- By Region: North America–27%, Europe–25%, Asia Pacific–30%, Others–18%.
Key players in the Soft tissue repair market are Smith & Nephew (UK), Arthrex, Inc. (US), Stryker Corporation (US), Johnson & Johnson (US), Medtronic (IE), Lifenet Health, Inc. (US), Becton, Dickinson and Company (US), Integra Lifesciences Corporation (US), Organogenesis Inc. (US), Zimmer Biomet (US), Baxter International, Inc. (US), ACell Inc. (US), Tissue Regenix Group Plc (UK), Aroa Biosurgery Ltd. (NZ), Artivion Inc. (US), CONMED Corporation (US), Meril Lifesciences Pvt Ltd. (India), RTI Surgical (US), Samyang Holdings Corporation (South Korea), Acera Surgical Inc. (US), Orthocell Ltd. (Australia), Biocer Entwicklungs Gmbh (Germany), Isto Biologics (US), Betatech Medical (Turkey), and Mimedx (US)
Research Coverage:
The report analyzes the soft tissue repair market and aims to estimate the market size and future growth potential of this market based on various segments such as product, application, end user, and region. The report also includes a competitive analysis of the key players in this market, along with their company profiles, service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will help market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall soft tissue repair market and the subsegments. It will also help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers:
Analysis of key drivers (increasing geriatric population and obesity rate, rising incidence of sports injuries and trauma cases, growing focus on R&D for technologically advanced soft tissue repair product manufacturing, increasing volume of surgeries) restraints (unfavorable reimbursement scenario, high cost of advanced orthodontic treatment and surgical procedures) opportunities (growing adoption of regenerative medicine and biologics in emerging economies, increasing use of combination materials for enhancing product efficacy), challenges (stringent regulatory framework, shortage of skilled surgeons and specialized facilities)
- Market Penetration: The report includes extensive information on products offered by the major players in the global soft tissue repair market. It also includes various segments by product, application, end user, and region.
- Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global soft tissue repair market.
- Market Development: Thorough knowledge and analysis of the profitable rising markets by product, application, end user, and region.
- Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global soft tissue repair market.
- Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the global soft tissue repair market.
Table of Contents
1 INTRODUCTION 26
1.1 STUDY OBJECTIVES 26
1.2 MARKET DEFINITION 26
1.3 STUDY SCOPE 27
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 27
1.3.2 INCLUSIONS & EXCLUSIONS 28
1.3.3 YEARS CONSIDERED 28
1.3.4 CURRENCY CONSIDERED 28
1.4 STAKEHOLDERS 29
1.5 SUMMARY OF CHANGES 29
2 RESEARCH METHODOLOGY 30
2.1 RESEARCH APPROACH 30
2.1.1 SECONDARY DATA 30
2.1.1.1 Key sources of secondary data 31
2.1.1.2 Key data from secondary sources 32
2.1.2 PRIMARY DATA 32
2.1.2.1 Key primary sources 33
2.1.2.2 Key objectives of primary research 33
2.1.2.3 Key data from primary sources 34
2.1.2.4 Key industry insights 34
2.1.2.5 Breakdown of primaries 35
2.2 MARKET SIZE ESTIMATION 36
2.2.1 REVENUE SHARE ANALYSIS 36
2.2.2 BOTTOM-UP APPROACH (SUPPLY-SIDE ANALYSIS) 37
2.2.3 TOP-DOWN APPROACH (BASED ON UTILIZATION RATE
AND ADOPTION PATTERN) 38
2.2.4 COMPANY PRESENTATIONS & PRIMARY INTERVIEWS 39
2.2.5 VOLUME ESTIMATION 39
2.3 GROWTH FORECAST 40
2.4 DATA TRIANGULATION 42
2.5 RESEARCH LIMITATIONS 43
2.5.1 SCOPE-RELATED LIMITATIONS 43
2.5.2 METHODOLOGY-RELATED LIMITATIONS 43
2.6 RISK ANALYSIS 43
2.7 STUDY ASSUMPTIONS 44
3 EXECUTIVE SUMMARY 45
4 PREMIUM INSIGHTS 49
4.1 SOFT TISSUE REPAIR MARKET OVERVIEW 49
4.2 SOFT TISSUE REPAIR MARKET: REGIONAL MIX 50
4.3 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY PRODUCT AND COUNTRY (2024) 51
4.4 SOFT TISSUE REPAIR MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 52
4.5 SOFT TISSUE REPAIR MARKET: DEVELOPED VS. EMERGING MARKETS 52
5 MARKET OVERVIEW 53
5.1 INTRODUCTION 53
5.2 MARKET DYNAMICS 53
5.2.1 DRIVERS 54
5.2.1.1 Increasing geriatric population and rising prevalence of obesity 54
5.2.1.2 Increasing occurrence of sports injuries 54
5.2.1.3 Rise in R&D investments and launch of technologically
advanced products 55
5.2.1.4 High volume of surgeries and advancements in
regenerative technologies 55
5.2.2 RESTRAINTS 57
5.2.2.1 Unfavorable reimbursement scenario 57
5.2.2.2 High cost of soft tissue repair products and surgical procedures 57
5.2.3 OPPORTUNITIES 58
5.2.3.1 Growing adoption of advanced soft tissue repair products in emerging economies 58
5.2.3.2 Rising use of combination materials for enhancing product efficacy 59
5.2.4 CHALLENGES 59
5.2.4.1 Stringent regulatory framework 59
5.2.4.2 Requirement of skilled personnel for effective use of
soft tissue repair products 60
5.3 ECOSYSTEM ANALYSIS 60
5.3.1 ROLE IN ECOSYSTEM 61
5.4 PRICING ANALYSIS 61
5.4.1 AVERAGE SELLING PRICE TREND OF SYNTHETIC MESHES,
BY REGION, 2022–2024 61
5.4.2 AVERAGE SELLING PRICE FOR SOFT TISSUE REPAIR PRODUCTS,
BY TYPE, 2023 62
5.4.3 AVERAGE SELLING PRICE TREND OF SOFT TISSUE REPAIR PRODUCTS,
BY KEY PLAYER, 2022–2024 62
5.5 SUPPLY CHAIN ANALYSIS 63
5.6 PATENT ANALYSIS 64
5.6.1 PATENT PUBLICATION TRENDS FOR SOFT TISSUE REPAIR MARKET 64
5.6.2 TOP APPLICANTS (COMPANIES) OF SOFT TISSUE REPAIR PATENTS 65
5.6.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN SOFT TISSUE REPAIR MARKET 66
5.6.4 LIST OF MAJOR PATENTS 66
5.7 VALUE CHAIN ANALYSIS 67
5.8 TECHNOLOGY ANALYSIS 68
5.8.1 KEY TECHNOLOGIES 68
5.8.1.1 Stem cell and regenerative therapies 68
5.8.1.2 Suture anchors and fixation devices 68
5.8.2 ADJACENT TECHNOLOGIES 68
5.8.2.1 3D bioprinting and tissue engineering 68
5.8.2.2 Regenerative medicine and biologics 69
5.8.3 COMPLEMENTARY TECHNOLOGIES 69
5.8.3.1 Wound closure and hemostatic devices 69
5.9 TRADE ANALYSIS 70
5.9.1 IMPORT DATA FOR HS CODE 300640, 2019–2023 70
5.9.2 EXPORT DATA FOR HS CODE 300640, 2019–2023 70
5.10 KEY CONFERENCES & EVENTS, 2025–2026 71
5.11 REGULATORY ANALYSIS 72
5.11.1 REGULATORY FRAMEWORK 72
5.11.1.1 North America 72
5.11.1.1.1 US 72
5.11.1.1.2 Canada 72
5.11.1.2 Europe 72
5.11.1.3 Asia Pacific 72
5.11.1.3.1 China 72
5.11.1.3.2 Japan 72
5.11.1.3.3 India 73
5.11.1.4 Latin America 73
5.11.1.4.1 Brazil 73
5.11.1.4.2 Mexico 73
5.11.1.5 Middle East 73
5.11.1.6 Africa 74
5.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES
AND OTHER ORGANIZATIONS 74
5.12 PORTER’S FIVE FORCES ANALYSIS 76
5.12.1 THREAT OF NEW ENTRANTS 77
5.12.2 INTENSITY OF COMPETITIVE RIVALRY 78
5.12.3 BARGAINING POWER OF BUYERS 78
5.12.4 BARGAINING POWER OF SUPPLIERS 79
5.12.5 THREAT OF SUBSTITUTES 79
5.13 KEY STAKEHOLDERS & BUYING CRITERIA 79
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 79
5.13.2 KEY BUYING CRITERIA 80
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 81
5.15 CASE STUDY ANALYSIS 82
5.15.1 TREATMENT OF CHRONIC SHOULDER INSTABILITY USING REGENETEN BIOINDUCTIVE IMPLANTS 82
5.15.2 TREATMENT OF INCISIONAL HERNIA USING PARIETEX COMPOSITE VENTRAL PATCHES BY MEDTRONIC 82
5.15.3 HEALING CHRONIC DIABETIC FOOT ULCERS WITH BILAYER WOUND MATRIX 83
5.16 INVESTMENT & FUNDING SCENARIO 83
5.17 REIMBURSEMENT SCENARIO ANALYSIS 84
5.18 END-USER EXPECTATIONS 84
5.19 IMPACT OF AI/GEN AI ON SOFT TISSUE REPAIR MARKET 85
5.20 IMPACT OF 2025 US TARIFF ON SOFT TISSUE REPAIR MARKET 86
5.20.1 INTRODUCTION 86
5.20.2 KEY TARIFF RATES 87
5.20.3 PRICE IMPACT ANALYSIS 88
5.20.4 IMPACT ON END-USE INDUSTRIES 88
6 SOFT TISSUE REPAIR MARKET, BY PRODUCT 90
6.1 INTRODUCTION 91
6.2 TISSUE PATCHES/MESHES 91
6.2.1 SYNTHETIC MESHES 93
6.2.1.1 Cost-effectiveness and minimal risk of donor-to-host infectious disease transmission to aid market growth 93
6.2.2 BIOLOGICAL MESHES 95
6.2.2.1 Allografts 97
6.2.2.1.1 Better biocompatibility to fuel adoption in surgeries and organ transplants 97
6.2.2.2 Xenografts 98
6.2.2.2.1 Availability in multiple sizes to make xenografts more viable alternative in soft tissue repair procedures 98
6.2.3 FIXATION PRODUCTS 99
6.2.3.1 Suture anchors 101
6.2.3.1.1 Increasing number of soft tissue injuries and growing need for surgeries to augment segment growth 101
6.2.3.2 Interference screws 102
6.2.3.2.1 Rise in injuries among geriatric population and availability of biodegradable interference screws to drive segment 102
6.2.3.3 Other fixation products 103
6.3 LAPAROSCOPIC INSTRUMENTS 104
6.3.1 QUICKER RECOVERY TIME, DECREASED PAIN, LOWER INFECTION RATES, AND REDUCED DISEASE RECURRENCE TO DRIVE MARKET 104
6.4 OTHER PRODUCTS 105
7 SOFT TISSUE REPAIR MARKET, BY APPLICATION 106
7.1 INTRODUCTION 107
7.2 HERNIA REPAIR 107
7.2.1 RISING ADOPTION OF TENSION-FREE HERNIA REPAIR PROCEDURES TO
FUEL MARKET GROWTH 107
7.3 SKIN REPAIR 109
7.3.1 RISING CASES OF BURN INJURIES TO SUPPORT MARKET GROWTH 109
7.4 ORTHOPEDIC SOFT TISSUE REPAIR 110
7.4.1 INCREASING SPORTS INJURIES AMONG ATHLETES AND RISING INCIDENCE OF ARTHRITIS IN ELDERLY TO FAVOR MARKET GROWTH 110
7.5 DENTAL SOFT TISSUE REPAIR 111
7.5.1 RISING NUMBER OF PREVENTIVE AND COSMETIC DENTAL PROCEDURES TO PROPEL MARKET GROWTH 111
7.6 BREAST RECONSTRUCTION 113
7.6.1 PREVALENCE OF BREAST CANCER AND INCREASING PATIENTS UNDERGOING MASTECTOMY TO AUGMENT MARKET GROWTH 113
7.7 DURAL REPAIR 114
7.7.1 RISING PREVALENCE OF NEUROVASCULAR DISORDERS TO DRIVE MARKET 114
7.8 VAGINAL SLINGS 115
7.8.1 INCREASED OCCURRENCE OF STRESS-INDUCED URINARY INCONTINENCE (SUI) TO BOOST MARKET GROWTH 115
7.9 OTHER APPLICATIONS 116
8 SOFT TISSUE REPAIR MARKET, BY END USER 118
8.1 INTRODUCTION 119
8.2 HOSPITALS & CLINICS 119
8.2.1 RISING NUMBER OF REIMBURSED IN-PATIENT PROCEDURES
TO DRIVE MARKET 119
8.3 AMBULATORY SURGICAL CENTERS 121
8.3.1 QUICKER CONSULTATION SERVICES AND MINIMAL PATIENT STAY
TO FUEL MARKET GROWTH 121
8.4 OTHER END USERS 122
9 SOFT TISSUE REPAIR MARKET, BY REGION 123
9.1 INTRODUCTION 124
9.2 NORTH AMERICA 125
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 125
9.2.2 US 129
9.2.2.1 US to dominate North American soft tissue repair market
during forecast period 129
9.2.3 CANADA 131
9.2.3.1 High healthcare expenditure and favorable public & private funding to support market growth 131
9.3 EUROPE 134
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 135
9.3.2 GERMANY 138
9.3.2.1 Advanced healthcare infrastructure and favorable surgical reimbursement to propel market growth 138
9.3.3 FRANCE 140
9.3.3.1 Well-established healthcare system and high geriatric population to boost market growth 140
9.3.4 UK 143
9.3.4.1 Increasing hernia repair and cardiovascular surgeries to stimulate market growth 143
9.3.5 ITALY 146
9.3.5.1 Favorable government initiatives and high demand for surgical interventions to support market growth 146
9.3.6 SPAIN 148
9.3.6.1 Increasing healthcare budget and rising focus on local medical product manufacturing to drive market 148
9.3.7 REST OF EUROPE 151
9.4 ASIA PACIFIC 154
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 154
9.4.2 JAPAN 158
9.4.2.1 Strong healthcare system and high geriatric population to favor market growth 158
9.4.3 CHINA 161
9.4.3.1 Increasing number of hospitals and rising focus on healthcare policy reforms to stimulate market growth 161
9.4.4 INDIA 164
9.4.4.1 Greater healthcare awareness and increased government support to aid market growth 164
9.4.5 AUSTRALIA 167
9.4.5.1 Increasing government support and rising healthcare expenditure to support market growth 167
9.4.6 SOUTH KOREA 170
9.4.6.1 Advanced healthcare infrastructure and adoption of minimally invasive surgical technologies to fuel market growth 170
9.4.7 REST OF ASIA PACIFIC 173
9.5 LATIN AMERICA 175
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 176
9.5.2 BRAZIL 178
9.5.2.1 Strong public healthcare system and favorable government-led initiatives to aid market growth 178
9.5.3 MEXICO 181
9.5.3.1 Increased focus on healthcare modernization and surgical innovation to favor market growth 181
9.5.4 REST OF LATIN AMERICA 184
9.6 MIDDLE EAST & AFRICA 187
9.6.1 ADVANCED HEALTHCARE INFRASTRUCTURE AND FAVORABLE GOVERNMENT POLICIES TO DRIVE MARKET 187
9.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 188
9.7 GCC COUNTRIES 190
9.7.1 FOCUS ON MEDICAL TOURISM AND AVAILABILITY OF ADVANCED SURGICAL PROCEDURES TO AID MARKET GROWTH 190
9.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES 191
10 COMPETITIVE LANDSCAPE 194
10.1 INTRODUCTION 194
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 194
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN
SOFT TISSUE REPAIR MARKET 195
10.3 REVENUE ANALYSIS, 2020–2024 196
10.4 MARKET SHARE ANALYSIS, 2024 197
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 200
10.5.1 STARS 200
10.5.2 EMERGING LEADERS 200
10.5.3 PERVASIVE PLAYERS 200
10.5.4 PARTICIPANTS 200
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 202
10.5.5.1 Company footprint 202
10.5.5.2 Region footprint 203
10.5.5.3 Product footprint 204
10.5.5.4 Application footprint 205
10.5.5.5 End-user footprint 206
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 207
10.6.1 PROGRESSIVE COMPANIES 207
10.6.2 RESPONSIVE COMPANIES 207
10.6.3 DYNAMIC COMPANIES 207
10.6.4 STARTING BLOCKS 207
10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 209
10.6.5.1 Detailed list of key startups/SMEs 209
10.6.5.2 Competitive benchmarking of startups/SMEs 210
10.7 COMPANY VALUATION & FINANCIAL METRICS 210
10.7.1 FINANCIAL METRICS 210
10.7.2 COMPANY VALUATION 211
10.8 R&D EXPENDITURE 211
10.9 BRAND/PRODUCT COMPARISON 212
10.10 COMPETITIVE SCENARIO 212
10.10.1 PRODUCT LAUNCHES 212
10.10.2 DEALS 213
10.10.3 EXPANSIONS 214
11 COMPANY PROFILES 215
11.1 KEY PLAYERS 215
11.1.1 ARTHREX, INC. 215
11.1.1.1 Business overview 215
11.1.1.2 Products offered 215
11.1.1.3 MnM view 217
11.1.1.3.1 Right to win 217
11.1.1.3.2 Strategic choices 217
11.1.1.3.3 Weaknesses & competitive threats 217
11.1.2 SMITH & NEPHEW PLC 218
11.1.2.1 Business overview 218
11.1.2.2 Products offered 219
11.1.2.3 Recent developments 220
11.1.2.3.1 Product launches 220
11.1.2.3.2 Deals 221
11.1.2.3.3 Expansions 221
11.1.2.4 MnM view 221
11.1.2.4.1 Right to win 221
11.1.2.4.2 Strategic choices 222
11.1.2.4.3 Weaknesses & competitive threats 222
11.1.3 JOHNSON & JOHNSON SERVICES, INC. 223
11.1.3.1 Business overview 223
11.1.3.2 Products offered 224
11.1.3.3 Recent developments 226
11.1.3.3.1 Deals 226
11.1.3.4 MnM view 226
11.1.3.4.1 Right to win 226
11.1.3.4.2 Strategic choices 226
11.1.3.4.3 Weaknesses & competitive threats 227
11.1.4 BECTON, DICKINSON AND COMPANY (BD) 228
11.1.4.1 Business overview 228
11.1.4.2 Products offered 229
11.1.4.3 MnM view 231
11.1.4.3.1 Right to win 231
11.1.4.3.2 Strategic choices 231
11.1.4.3.3 Weaknesses & competitive threats 231
11.1.5 STRYKER 232
11.1.5.1 Business overview 232
11.1.5.2 Products offered 233
11.1.5.3 MnM view 234
11.1.5.3.1 Right to win 234
11.1.5.3.2 Strategic choices 234
11.1.5.3.3 Weaknesses & competitive threats 234
11.1.6 MEDTRONIC 235
11.1.6.1 Business overview 235
11.1.6.2 Products offered 236
11.1.6.3 Recent developments 238
11.1.6.3.1 Deals 238
11.1.6.3.2 Expansions 238
11.1.6.3.3 Other developments 238
11.1.7 ZIMMER BIOMET 239
11.1.7.1 Business overview 239
11.1.7.2 Products offered 240
11.1.7.3 Recent developments 241
11.1.7.3.1 Deals 241
11.1.8 INTEGRA LIFESCIENCES CORPORATION 242
11.1.8.1 Business overview 242
11.1.8.2 Products offered 243
11.1.9 ARTIVION, INC. 245
11.1.9.1 Business overview 245
11.1.9.2 Products offered 246
11.1.10 ORGANOGENESIS INC. 248
11.1.10.1 Business overview 248
11.1.10.2 Products offered 249
11.1.11 LIFENET HEALTH 250
11.1.11.1 Business overview 250
11.1.11.2 Products offered 250
11.1.12 BAXTER 252
11.1.12.1 Business overview 252
11.1.12.2 Products offered 253
11.1.13 TISSUE REGENIX 254
11.1.13.1 Business overview 254
11.1.13.2 Products offered 255
11.1.14 CONMED CORPORATION 257
11.1.14.1 Business overview 257
11.1.14.2 Products offered 258
11.1.15 MERIL LIFE SCIENCES PVT. LTD. 260
11.1.15.1 Business overview 260
11.1.15.2 Products offered 260
11.1.16 RTI SURGICAL 261
11.1.16.1 Business overview 261
11.1.16.2 Products offered 261
11.2 OTHER PLAYERS 262
11.2.1 SAMYANG HOLDINGS CORPORATION 262
11.2.2 AROA BIOSURGERY LIMITED 263
11.2.3 ACERA SURGICAL INC. 263
11.2.4 ORTHOCELL LTD. 264
11.2.5 ACELL, INC. 264
11.2.6 BIOCER ENTWICKLUNGS-GMBH 265
11.2.7 ISTO BIOLOGICS 265
11.2.8 BETATECH MEDICAL 266
11.2.9 MIMEDX GROUP, INC. 267
12 APPENDIX 268
12.1 DISCUSSION GUIDE 268
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 272
12.3 CUSTOMIZATION OPTIONS 274
12.4 RELATED REPORTS 274
12.5 AUTHOR DETAILS 275
LIST OF TABLES
TABLE 1 SOFT TISSUE REPAIR MARKET: INCLUSIONS & EXCLUSIONS 28
TABLE 2 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 29
TABLE 3 SOFT TISSUE REPAIR MARKET: RISK ANALYSIS 43
TABLE 4 SOFT TISSUE REPAIR MARKET: STUDY ASSUMPTIONS 44
TABLE 5 UK: INCREASE IN NUMBER OF CARDIAC SURGICAL PROCEDURES PERFORMED 56
TABLE 6 US VS. INDIA: COST OF SURGICAL PROCEDURES, 2023 (USD) 58
TABLE 7 SOFT TISSUE REPAIR MARKET: ROLE IN ECOSYSTEM 61
TABLE 8 AVERAGE SELLING PRICE TREND OF SYNTHETIC MESHES,
BY REGION, 2022–2024 (USD) 61
TABLE 9 AVERAGE SELLING PRICE FOR SOFT TISSUE REPAIR PRODUCTS, BY TYPE, 2023 62
TABLE 10 AVERAGE SELLING PRICE OF SOFT TISSUE REPAIR PRODUCTS,
BY KEY PLAYER, 2022–2024 (USD) 62
TABLE 11 SOFT TISSUE REPAIR MARKET: LIST OF MAJOR PATENTS 66
TABLE 12 IMPORT DATA FOR HS CODE 300640, BY COUNTRY,
2019–2023 (USD THOUSAND) 70
TABLE 13 EXPORT DATA FOR HS CODE 300640, BY COUNTRY,
2019–2023 (USD THOUSAND) 70
TABLE 14 SOFT TISSUE REPAIR MARKET: LIST OF KEY CONFERENCES & EVENTS,
JANUARY 2025–DECEMBER 2026 71
TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 74
TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 74
TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 75
TABLE 18 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 76
TABLE 19 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 76
TABLE 20 SOFT TISSUE REPAIR MARKET: PORTER’S FIVE FORCES 76
TABLE 21 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR
TOP THREE APPLICATIONS (%) 80
TABLE 22 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 80
TABLE 23 CASE STUDY 1: TREATMENT OF CHRONIC SHOULDER INSTABILITY USING REGENETEN BIOINDUCTIVE IMPLANTS 82
TABLE 24 CASE STUDY 2: TREATMENT OF INCISIONAL HERNIA USING PARIETEX COMPOSITE VENTRAL PATCHES BY MEDTRONIC 82
TABLE 25 CASE STUDY 3: HEALING CHRONIC DIABETIC FOOT ULCERS WITH
BILAYER WOUND MATRIX 83
TABLE 26 SOFT TISSUE REPAIR MARKET: END-USER EXPECTATIONS 84
TABLE 27 IMPACT OF AI/GEN AI ON SOFT TISSUE REPAIR MARKET 85
TABLE 28 US-ADJUSTED RECIPROCAL TARIFF RATES 87
TABLE 29 SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 91
TABLE 30 SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE,
2023–2030 (USD MILLION) 92
TABLE 31 SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY COUNTRY, 2023–2030 (USD MILLION) 92
TABLE 32 SYNTHETIC MESHES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 94
TABLE 33 SYNTHETIC MESHES MARKET, BY REGION, 2023–2030 (THOUSAND UNITS) 95
TABLE 34 BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION) 95
TABLE 35 BIOLOGICAL MESHES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 96
TABLE 36 BIOLOGICAL MESHES MARKET, BY REGION, 2023–2030 (THOUSAND UNITS) 97
TABLE 37 ALLOGRAFTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 98
TABLE 38 XENOGRAFTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 99
TABLE 39 FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 100
TABLE 40 FIXATION PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 100
TABLE 41 SUTURE ANCHORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 101
TABLE 42 INTERFERENCE SCREWS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 102
TABLE 43 OTHER FIXATION PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 103
TABLE 44 SOFT TISSUE REPAIR MARKET FOR LAPAROSCOPIC INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 104
TABLE 45 SOFT TISSUE REPAIR MARKET FOR OTHER PRODUCTS, BY COUNTRY,
2023–2030 (USD MILLION) 105
TABLE 46 SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 107
TABLE 47 HERNIA REPAIR MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 108
TABLE 48 SKIN REPAIR MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 109
TABLE 49 ORTHOPEDIC SOFT TISSUE REPAIR MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 111
TABLE 50 DENTAL SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 112
TABLE 51 BREAST RECONSTRUCTION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 114
TABLE 52 DURAL REPAIR MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 115
TABLE 53 VAGINAL SLINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 116
TABLE 54 OTHER APPLICATIONS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 117
TABLE 55 SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION) 119
TABLE 56 SOFT TISSUE REPAIR MARKET FOR HOSPITALS & CLINICS, BY COUNTRY,
2023–2030 (USD MILLION) 120
TABLE 57 SOFT TISSUE REPAIR MARKET FOR AMBULATORY SURGICAL CENTERS,
BY COUNTRY, 2023–2030 (USD MILLION) 121
TABLE 58 SOFT TISSUE REPAIR MARKET FOR OTHER END USERS, BY COUNTRY,
2023–2030 (USD MILLION) 122
TABLE 59 SOFT TISSUE REPAIR MARKET, BY REGION, 2023–2030 (USD MILLION) 125
TABLE 60 NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 126
TABLE 61 NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 127
TABLE 62 NORTH AMERICA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION) 127
TABLE 63 NORTH AMERICA: BIOLOGICAL MESHES MARKET, BY TYPE,
2023–2030 (USD MILLION) 127
TABLE 64 NORTH AMERICA: FIXATION PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 128
TABLE 65 NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 128
TABLE 66 NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY END USER,
2023–2030 (USD MILLION) 128
TABLE 67 US: KEY MACROINDICATORS 129
TABLE 68 US: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 129
TABLE 69 US: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION) 130
TABLE 70 US: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION) 130
TABLE 71 US: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 130
TABLE 72 US: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 131
TABLE 73 US: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION) 131
TABLE 74 CANADA: KEY MACROINDICATORS 132
TABLE 75 CANADA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 132
TABLE 76 CANADA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION) 133
TABLE 77 CANADA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION) 133
TABLE 78 CANADA: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 133
TABLE 79 CANADA: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 134
TABLE 80 CANADA: SOFT TISSUE REPAIR MARKET, BY END USER,
2023–2030 (USD MILLION) 134
TABLE 81 EUROPE: SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 135
TABLE 82 EUROPE: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 136
TABLE 83 EUROPE: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION) 136
TABLE 84 EUROPE: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION) 136
TABLE 85 EUROPE: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 137
TABLE 86 EUROPE: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 137
TABLE 87 EUROPE: SOFT TISSUE REPAIR MARKET, BY END USER,
2023–2030 (USD MILLION) 137
TABLE 88 GERMANY: KEY MACROINDICATORS 138
TABLE 89 GERMANY: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 138
TABLE 90 GERMANY: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES,
BY TYPE, 2023–2030 (USD MILLION) 139
TABLE 91 GERMANY: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION) 139
TABLE 92 GERMANY: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 139
TABLE 93 GERMANY: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 140
TABLE 94 GERMANY: SOFT TISSUE REPAIR MARKET, BY END USER,
2023–2030 (USD MILLION) 140
TABLE 95 FRANCE: KEY MACROINDICATORS 141
TABLE 96 FRANCE: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 141
TABLE 97 FRANCE: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION) 141
TABLE 98 FRANCE: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION) 142
TABLE 99 FRANCE: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 142
TABLE 100 FRANCE: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 142
TABLE 101 FRANCE: SOFT TISSUE REPAIR MARKET, BY END USER,
2023–2030 (USD MILLION) 143
TABLE 102 UK: KEY MACROINDICATORS 143
TABLE 103 UK: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 144
TABLE 104 UK: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION) 144
TABLE 105 UK: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION) 144
TABLE 106 UK: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 145
TABLE 107 UK: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 145
TABLE 108 UK: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION) 145
TABLE 109 ITALY: KEY MACROINDICATORS 146
TABLE 110 ITALY: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 146
TABLE 111 ITALY: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION) 147
TABLE 112 ITALY: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION) 147
TABLE 113 ITALY: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 147
TABLE 114 ITALY: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 148
TABLE 115 ITALY: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION) 148
TABLE 116 SPAIN: KEY MACROINDICATORS 149
TABLE 117 SPAIN: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 149
TABLE 118 SPAIN: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION) 150
TABLE 119 SPAIN: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION) 150
TABLE 120 SPAIN: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 150
TABLE 121 SPAIN: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 151
TABLE 122 SPAIN: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION) 151
TABLE 123 REST OF EUROPE: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 152
TABLE 124 REST OF EUROPE: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION) 152
TABLE 125 REST OF EUROPE: BIOLOGICAL MESHES MARKET, BY TYPE,
2023–2030 (USD MILLION) 153
TABLE 126 REST OF EUROPE: FIXATION PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 153
TABLE 127 REST OF EUROPE: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 153
TABLE 128 REST OF EUROPE: SOFT TISSUE REPAIR MARKET, BY END USER,
2023–2030 (USD MILLION) 154
TABLE 129 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 156
TABLE 130 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 156
TABLE 131 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES,
BY TYPE, 2023–2030 (USD MILLION) 156
TABLE 132 ASIA PACIFIC: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION) 157
TABLE 133 ASIA PACIFIC: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 157
TABLE 134 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 157
TABLE 135 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY END USER,
2023–2030 (USD MILLION) 158
TABLE 136 JAPAN: KEY MACROINDICATORS 159
TABLE 137 JAPAN: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 159
TABLE 138 JAPAN: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION) 159
TABLE 139 JAPAN: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION) 160
TABLE 140 JAPAN: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 160
TABLE 141 JAPAN: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 160
TABLE 142 JAPAN: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION) 161
TABLE 143 CHINA: KEY MACROINDICATORS 162
TABLE 144 CHINA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 162
TABLE 145 CHINA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION) 162
TABLE 146 CHINA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION) 163
TABLE 147 CHINA: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 163
TABLE 148 CHINA: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 163
TABLE 149 CHINA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION) 164
TABLE 150 INDIA: KEY MACROINDICATORS 165
TABLE 151 INDIA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 165
TABLE 152 INDIA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION) 165
TABLE 153 INDIA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION) 166
TABLE 154 INDIA: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 166
TABLE 155 INDIA: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 166
TABLE 156 INDIA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION) 167
TABLE 157 AUSTRALIA: KEY MACROINDICATORS 168
TABLE 158 AUSTRALIA: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 168
TABLE 159 AUSTRALIA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES,
BY TYPE, 2023–2030 (USD MILLION) 168
TABLE 160 AUSTRALIA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION) 169
TABLE 161 AUSTRALIA: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 169
TABLE 162 AUSTRALIA: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 169
TABLE 163 AUSTRALIA: SOFT TISSUE REPAIR MARKET, BY END USER,
2023–2030 (USD MILLION) 170
TABLE 164 SOUTH KOREA: KEY MACROINDICATORS 171
TABLE 165 SOUTH KOREA: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 171
TABLE 166 SOUTH KOREA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES,
BY TYPE, 2023–2030 (USD MILLION) 171
TABLE 167 SOUTH KOREA: BIOLOGICAL MESHES MARKET, BY TYPE,
2023–2030 (USD MILLION) 172
TABLE 168 SOUTH KOREA: FIXATION PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 172
TABLE 169 SOUTH KOREA: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 172
TABLE 170 SOUTH KOREA: SOFT TISSUE REPAIR MARKET, BY END USER,
2023–2030 (USD MILLION) 173
TABLE 171 REST OF ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 173
TABLE 172 REST OF ASIA PACIFIC: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION) 174
TABLE 173 REST OF ASIA PACIFIC: BIOLOGICAL MESHES MARKET, BY TYPE,
2023–2030 (USD MILLION) 174
TABLE 174 REST OF ASIA PACIFIC: FIXATION PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 174
TABLE 175 REST OF ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 175
TABLE 176 REST OF ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY END USER,
2023–2030 (USD MILLION) 175
TABLE 177 LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 176
TABLE 178 LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 176
TABLE 179 LATIN AMERICA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES,
BY TYPE, 2023–2030 (USD MILLION) 177
TABLE 180 LATIN AMERICA: BIOLOGICAL MESHES MARKET, BY TYPE,
2023–2030 (USD MILLION) 177
TABLE 181 LATIN AMERICA: FIXATION PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 177
TABLE 182 LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 178
TABLE 183 LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY END USER,
2023–2030 (USD MILLION) 178
TABLE 184 BRAZIL: KEY MACROINDICATORS 179
TABLE 185 BRAZIL: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 179
TABLE 186 BRAZIL: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION) 180
TABLE 187 BRAZIL: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION) 180
TABLE 188 BRAZIL: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 180
TABLE 189 BRAZIL: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 181
TABLE 190 BRAZIL: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION) 181
TABLE 191 MEXICO: KEY MACROINDICATORS 182
TABLE 192 MEXICO: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 182
TABLE 193 MEXICO: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION) 183
TABLE 194 MEXICO: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION) 183
TABLE 195 MEXICO: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 183
TABLE 196 MEXICO: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 184
TABLE 197 MEXICO: SOFT TISSUE REPAIR MARKET, BY END USER,
2023–2030 (USD MILLION) 184
TABLE 198 REST OF LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 185
TABLE 199 REST OF LATIN AMERICA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION) 185
TABLE 200 REST OF LATIN AMERICA: BIOLOGICAL MESHES MARKET, BY TYPE,
2023–2030 (USD MILLION) 186
TABLE 201 REST OF LATIN AMERICA: FIXATION PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 186
TABLE 202 REST OF LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 186
TABLE 203 REST OF LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY END USER,
2023–2030 (USD MILLION) 187
TABLE 204 MIDDLE EAST & AFRICA: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 188
TABLE 205 MIDDLE EAST & AFRICA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION) 189
TABLE 206 MIDDLE EAST & AFRICA: BIOLOGICAL MESHES MARKET, BY TYPE,
2023–2030 (USD MILLION) 189
TABLE 207 MIDDLE EAST & AFRICA: FIXATION PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 189
TABLE 208 MIDDLE EAST & AFRICA: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 190
TABLE 209 MIDDLE EAST & AFRICA: SOFT TISSUE REPAIR MARKET, BY END USER,
2023–2030 (USD MILLION) 190
TABLE 210 GCC COUNTRIES: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 192
TABLE 211 GCC COUNTRIES: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION) 192
TABLE 212 GCC COUNTRIES: BIOLOGICAL MESHES MARKET, BY TYPE,
2023–2030 (USD MILLION) 192
TABLE 213 GCC COUNTRIES: FIXATION PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 193
TABLE 214 GCC COUNTRIES: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 193
TABLE 215 GCC COUNTRIES: SOFT TISSUE REPAIR MARKET, BY END USER,
2023–2030 (USD MILLION) 193
TABLE 216 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN
SOFT TISSUE REPAIR MARKET 195
TABLE 217 SOFT TISSUE REPAIR MARKET: DEGREE OF COMPETITION 198
TABLE 218 SOFT TISSUE REPAIR MARKET: REGION FOOTPRINT 203
TABLE 219 SOFT TISSUE REPAIR MARKET: PRODUCT FOOTPRINT 204
TABLE 220 SOFT TISSUE REPAIR MARKET: APPLICATION FOOTPRINT 205
TABLE 221 SOFT TISSUE REPAIR MARKET: END-USER FOOTPRINT 206
TABLE 222 SOFT TISSUE REPAIR MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS 209
TABLE 223 SOFT TISSUE REPAIR MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS, BY PRODUCT AND REGION 210
TABLE 224 SOFT TISSUE REPAIR MARKET: PRODUCT LAUNCHES, JANUARY 2022–APRIL 2025 212
TABLE 225 SOFT TISSUE REPAIR MARKET: DEALS, JANUARY 2022–APRIL 2025 213
TABLE 226 SOFT TISSUE REPAIR MARKET: EXPANSIONS, JANUARY 2022–APRIL 2025 214
TABLE 227 ARTHREX, INC.: COMPANY OVERVIEW 215
TABLE 228 ARTHREX, INC.: PRODUCTS OFFERED 215
TABLE 229 SMITH & NEPHEW PLC: COMPANY OVERVIEW 218
TABLE 230 SMITH & NEPHEW PLC: PRODUCTS OFFERED 219
TABLE 231 SMITH & NEPHEW PLC: PRODUCT LAUNCHES, JANUARY 2022–APRIL 2025 220
TABLE 232 SMITH & NEPHEW PLC: DEALS, JANUARY 2022–APRIL 2025 221
TABLE 233 SMITH & NEPHEW PLC: EXPANSIONS, JANUARY 2022–APRIL 2025 221
TABLE 234 JOHNSON & JOHNSON SERVICES, INC.: COMPANY OVERVIEW 223
TABLE 235 JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS OFFERED 224
TABLE 236 JOHNSON & JOHNSON SERVICES, INC.: DEALS, JANUARY 2022–APRIL 2025 226
TABLE 237 BECTON, DICKINSON AND COMPANY (BD): COMPANY OVERVIEW 228
TABLE 238 BECTON, DICKINSON AND COMPANY (BD): PRODUCTS OFFERED 229
TABLE 239 STRYKER: COMPANY OVERVIEW 232
TABLE 240 STRYKER: PRODUCTS OFFERED 233
TABLE 241 MEDTRONIC: COMPANY OVERVIEW 235
TABLE 242 MEDTRONIC: PRODUCTS OFFERED 236
TABLE 243 MEDTRONIC: DEALS, JANUARY 2022–APRIL 2025 238
TABLE 244 MEDTRONIC: EXPANSIONS: JANUARY 2022–APRIL 2025 238
TABLE 245 MEDTRONIC: OTHER DEVELOPMENTS: JANUARY 2022–APRIL 2025 238
TABLE 246 ZIMMER BIOMET: COMPANY OVERVIEW 239
TABLE 247 ZIMMER BIOMET: PRODUCTS OFFERED 240
TABLE 248 ZIMMER BIOMET: DEALS, JANUARY 2022–APRIL 2025 241
TABLE 249 INTEGRA LIFESCIENCES CORPORATION: COMPANY OVERVIEW 242
TABLE 250 INTEGRA LIFESCIENCES CORPORATION: PRODUCTS OFFERED 243
TABLE 251 ARTIVION, INC.: COMPANY OVERVIEW 245
TABLE 252 ARTIVION, INC.: PRODUCTS OFFERED 246
TABLE 253 ORGANOGENESIS INC.: COMPANY OVERVIEW 248
TABLE 254 ORGANOGENESIS INC.: PRODUCTS OFFERED 249
TABLE 255 LIFENET HEALTH: COMPANY OVERVIEW 250
TABLE 256 LIFENET HEALTH: PRODUCTS OFFERED 250
TABLE 257 BAXTER: COMPANY OVERVIEW 252
TABLE 258 BAXTER: PRODUCTS OFFERED 253
TABLE 259 TISSUE REGENIX: COMPANY OVERVIEW 254
TABLE 260 TISSUE REGENIX: PRODUCTS OFFERED 255
TABLE 261 CONMED CORPORATION: COMPANY OVERVIEW 257
TABLE 262 CONMED CORPORATION: PRODUCTS OFFERED 258
TABLE 263 MERIL LIFE SCIENCES PVT. LTD.: COMPANY OVERVIEW 260
TABLE 264 MERIL LIFE SCIENCES PVT. LTD.: PRODUCTS OFFERED 260
TABLE 265 RTI SURGICAL: COMPANY OVERVIEW 261
TABLE 266 RTI SURGICAL: PRODUCTS OFFERED 261
TABLE 267 SAMYANG HOLDINGS CORPORATION: COMPANY OVERVIEW 262
TABLE 268 AROA BIOSURGERY LIMITED: COMPANY OVERVIEW 263
TABLE 269 ACERA SURGICAL INC.: COMPANY OVERVIEW 263
TABLE 270 ORTHOCELL LTD.: COMPANY OVERVIEW 264
TABLE 271 ACELL, INC.: COMPANY OVERVIEW 264
TABLE 272 BIOCER ENTWICKLUNGS-GMBH: COMPANY OVERVIEW 265
TABLE 273 ISTO BIOLOGICS: COMPANY OVERVIEW 265
TABLE 274 BETATECH MEDICAL: COMPANY OVERVIEW 266
TABLE 275 MIMEDX GROUP, INC.: COMPANY OVERVIEW 267
LIST OF FIGURES
FIGURE 1 SOFT TISSUE REPAIR MARKET SEGMENTATION & REGIONAL SCOPE 27
FIGURE 2 SOFT TISSUE REPAIR MARKET: YEARS CONSIDERED 28
FIGURE 3 SOFT TISSUE REPAIR MARKET: RESEARCH DESIGN 30
FIGURE 4 SOFT TISSUE REPAIR MARKET: KEY DATA FROM SECONDARY SOURCES 32
FIGURE 5 SOFT TISSUE REPAIR MARKET: KEY PRIMARY SOURCES
(DEMAND AND SUPPLY SIDE) 33
FIGURE 6 SOFT TISSUE REPAIR MARKET: KEY DATA FROM PRIMARY SOURCES 34
FIGURE 7 SOFT TISSUE REPAIR MARKET: KEY INSIGHTS FROM INDUSTRY EXPERTS 34
FIGURE 8 BREAKDOWN OF PRIMARIES (SUPPLY SIDE): BY COMPANY TYPE,
DESIGNATION, AND REGION 35
FIGURE 9 BREAKDOWN OF PRIMARIES (DEMAND SIDE): BY END USER TYPE,
DESIGNATION, AND REGION 35
FIGURE 10 SOFT TISSUE REPAIR MARKET: MARKET SIZE ESTIMATION 36
FIGURE 11 SOFT TISSUE REPAIR MARKET: REVENUE SHARE ANALYSIS (SUPPLY SIDE) (2024) 37
FIGURE 12 SOFT TISSUE REPAIR MARKET: REVENUE SHARE ANALYSIS
(BOTTOM-UP APPROACH) (2024) 38
FIGURE 13 SOFT TISSUE REPAIR MARKET: TOP-DOWN APPROACH 39
FIGURE 14 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN SOFT TISSUE REPAIR MARKET 40
FIGURE 15 SOFT TISSUE REPAIR MARKET: CAGR PROJECTIONS (SUPPLY SIDE) (2024) 41
FIGURE 16 SOFT TISSUE REPAIR MARKET: DATA TRIANGULATION 42
FIGURE 17 SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 45
FIGURE 18 SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 46
FIGURE 19 SOFT TISSUE REPAIR MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 47
FIGURE 20 REGIONAL SNAPSHOT OF SOFT TISSUE REPAIR MARKET 48
FIGURE 21 INCREASING NUMBER OF HERNIA REPAIR SURGERIES AND
RISING R&D INVESTMENTS TO DRIVE MARKET 49
FIGURE 22 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 50
FIGURE 23 JAPAN AND TISSUE PATCHES/MESHES COMMANDED LARGEST
MARKET SHARE IN 2024 51
FIGURE 24 CANADA TO REGISTER HIGHEST GROWTH RATE FROM 2025 TO 2030 52
FIGURE 25 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES
DURING STUDY PERIOD 52
FIGURE 26 SOFT TISSUE REPAIR MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 53
FIGURE 27 SOFT TISSUE REPAIR MARKET: ECOSYSTEM ANALYSIS 60
FIGURE 28 SOFT TISSUE REPAIR MARKET: SUPPLY CHAIN ANALYSIS 63
FIGURE 29 TOP PATENT APPLICANTS/OWNERS (COMPANIES/INSTITUTES) FOR
SOFT TISSUE REPAIR (JANUARY 2014–APRIL 2025) 65
FIGURE 30 JURISDICTION ANALYSIS: TOP APPLICANT (COUNTRIES) FOR SOFT TISSUE REPAIR PATENTS, 2014–2025 66
FIGURE 31 SOFT TISSUE REPAIR MARKET: VALUE CHAIN ANALYSIS 67
FIGURE 32 SOFT TISSUE REPAIR MARKET: PORTER’S FIVE FORCES ANALYSIS 77
FIGURE 33 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR
TOP THREE APPLICATIONS 79
FIGURE 34 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 80
FIGURE 35 SOFT TISSUE REPAIR MARKET: TRENDS/DISRUPTIONS IMPACTING
CUSTOMER’S BUSINESS 81
FIGURE 36 SOFT TISSUE REPAIR MARKET: FUNDING AND NUMBER OF DEALS, 2021–2024 83
FIGURE 37 SOFT TISSUE REPAIR MARKET: IMPACT OF AI/GEN AI 86
FIGURE 38 CANADA TO REGISTER HIGHEST CAGR DURING STUDY PERIOD 124
FIGURE 39 NORTH AMERICA: SOFT TISSUE REPAIR MARKET SNAPSHOT 126
FIGURE 40 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET SNAPSHOT 155
FIGURE 41 REVENUE ANALYSIS OF KEY PLAYERS IN SOFT TISSUE REPAIR
MARKET, 2020–2024 197
FIGURE 42 MARKET SHARE ANALYSIS OF KEY PLAYERS IN SOFT TISSUE
REPAIR MARKET (2024) 198
FIGURE 43 SOFT TISSUE REPAIR MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2024 201
FIGURE 44 SOFT TISSUE REPAIR MARKET: COMPANY FOOTPRINT 202
FIGURE 45 SOFT TISSUE REPAIR MARKET: COMPANY EVALUATION MATRIX
(STARTUPS/SMES), 2024 208
FIGURE 46 EV/EBITDA OF KEY VENDORS 210
FIGURE 47 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK
BETA OF KEY VENDORS 211
FIGURE 48 SOFT TISSUE REPAIR MARKET: R&D EXPENDITURE OF
KEY PLAYERS (2023 VS. 2024) 211
FIGURE 49 SOFT TISSUE REPAIR MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 212
FIGURE 50 SMITH & NEPHEW PLC: COMPANY SNAPSHOT 219
FIGURE 51 JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT 224
FIGURE 52 BECTON, DICKINSON AND COMPANY (BD): COMPANY SNAPSHOT 228
FIGURE 53 STRYKER: COMPANY SNAPSHOT 233
FIGURE 54 MEDTRONIC: COMPANY SNAPSHOT 236
FIGURE 55 ZIMMER BIOMET: COMPANY SNAPSHOT 240
FIGURE 56 INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT 243
FIGURE 57 ARTIVION, INC.: COMPANY SNAPSHOT 246
FIGURE 58 ORGANOGENESIS INC.: COMPANY SNAPSHOT 248
FIGURE 59 BAXTER: COMPANY SNAPSHOT 253
FIGURE 60 TISSUE REGENIX: COMPANY SNAPSHOT 255
FIGURE 61 CONMED CORPORATION: COMPANY SNAPSHOT 258
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11